pembrolizumab
merck
['pembro', 'melanoma']
esmo 2022: neoadjuvant pembrolizumab safe, effective strategy for high-risk melanoma #oncology
Official Twitter account of @PracticeUpdate Oncology. Includes commentaries, journal scans, conference coverage, news items & more. Part of Elsevier.